Literature DB >> 6497350

Mutation and selection in the marker (X) syndrome. A hypothesis.

F Vogel.   

Abstract

Sherman et al. (1984) concluded from a cytogenetic and genetic analysis of families with the marker (X) syndrome that the rate of the mutation leading to this syndrome is extraordinarily high (7.2 X 10(-4) in male germ cells), and that these mutations occur exclusively in male germ cells. It is shown by some model calculations that the empirical evidence can be reconciled with more conventional assumptions on the mutation rate if a moderately increased fertility of clinically unaffected female and possibly male carriers in the past is assumed. Indirect evidence for such an increased fertility can be derived from old reports on higher reproduction of slightly subnormal individuals. On the other hand, complete compensation of gene loss in affected individuals by higher fertility of unaffected carriers appears to be rather unlikely. At present, a moderately high mutation rate--as found, for example, in Duchenne muscular dystrophy or haemophilia A--in combination with a moderately increased fertility of clinically unaffected carriers is the most likely alternative.

Entities:  

Mesh:

Year:  1984        PMID: 6497350     DOI: 10.1111/j.1469-1809.1984.tb00846.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  15 in total

1.  Estimating the stability of the proposed imprinted state of the fragile-X mutation when transmitted by females.

Authors:  P J Follette; C D Laird
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

2.  High proportion of twins in carriers of fragile X syndrome.

Authors:  E F Tizzano; M Baiget
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

3.  Population genetic consequences of the fragile-X syndrome, based on the X-inactivation imprinting model.

Authors:  J A Sved; C D Laird
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

Review 4.  Risk calculations for hereditary effects of ionizing radiation in humans.

Authors:  F Vogel
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

5.  Clinical features and reproductive patterns in fragile X female heterozygotes.

Authors:  D Z Loesch; D A Hay
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318

6.  Recurrent mutation pressure does not explain the prevalence of the marker (X) syndrome.

Authors:  F Vogel; J Krüger; K B Nielsen; J P Fryns; D Schindler; A Schinzel; A Schmidt; E Schwinger
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 7.  Research strategies in human behaviour genetics.

Authors:  F Vogel
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

8.  Transmission of the marker X syndrome trait by unaffected males: conclusions from studies of large families.

Authors:  U Froster-Iskenius; A Schulze; E Schwinger
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males.

Authors:  S L Sherman; P A Jacobs; N E Morton; U Froster-Iskenius; P N Howard-Peebles; K B Nielsen; M W Partington; G R Sutherland; G Turner; M Watson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  Origins of the fragile X syndrome mutation.

Authors:  M C Hirst; S J Knight; Z Christodoulou; P K Grewal; J P Fryns; K E Davies
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.